Skip to main content
. 2020 Apr 6;103(1):55–63. doi: 10.4269/ajtmh.19-0818

Table 3.

Summary of cutoff titer positivity criteria and antibody isotype described in selected studies

Positivity cutoff titer criteria Antibody target (n studies)
Single titer Both Only 4-fold Range Total IgM IgG Whole IgM/IgG Not stated Isotype total
Country
 American Samoa 1 1 1 1
 Australia 1 1 1 1
 Brazil 1 1 2 1 1
 China 2 2 1 1
 Colombia 1 1 2 1 1
 Croatia 1 1 2 1 1 2
 Cyprus 4 4 2 2
 Djibouti 1 1 1 1
 France 3 3 1 1 2
 Germany 1 1 1 1
 Greece 5 3 8 1 1 2 1 5
 Indonesia 1 3 4 1 1 2
 Israel 2 2 1 1 2
 Lao PDR 1 2 2 5 3 2 5
 Madagascar 1 1 1 1
 Malaysia 1 1 1 1 2
 Malta 1 1 1 1
 Morocco 1 1 1 1
 Nepal 1 1 1 3 1 1 2
 New Zealand 1 1 1 1
 Singapore 1 1 1 1
 Spain 8 2 1 11 1 4 4 9
 Sri Lanka 1 3 1 5 1 1 2
 Taiwan 6 7 13 6 1 7
 Tanzania 2 1 3 1 1 2
 Thailand 5 5 1 4 5
 Tunisia 6 3 9 2 1 2 1 6
 United States 2 4 6 3 1 2 6
 Vietnam 1 1 1 1
 Zambia 2 2 1 1
Total 57 30 13 2 102* 8 16 10 24 17 75
Study design
 Case series 21 13 4 1 39 6 3 4 17 9 39
 Cross-sectional studies 24 8 1 1 34 3 13 4 6 8 34
 Diagnostic accuracy studies 4 1 5 2 2 1 5
 Total 49 22 5 2 78 9 18 10 24 17 78
*

Some studies provided different positivity criteria for IgM and IgG.

Three studies were not included as they examined murine typhus in travelers from various countries.